These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15206161)

  • 1. [Adenovirus-mediated interleukin-12 gene therapy for prostate cancer].
    Nasu Y; Ebara S; Kumon H
    Nihon Rinsho; 2004 Jun; 62(6):1181-91. PubMed ID: 15206161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suicide gene therapy for prostate cancer--update of current development].
    Ebara S; Nasu Y
    Nihon Rinsho; 2003 Jul; 61(7):1257-65. PubMed ID: 12877094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice.
    Timme TL; Hall SJ; Barrios R; Woo SL; Aguilar-Cordova E; Thompson TC
    Cancer Gene Ther; 1998; 5(2):74-82. PubMed ID: 9570298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
    Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer.
    Hall SJ; Mutchnik SE; Yang G; Timme TL; Nasu Y; Bangma CH; Woo SL; Shaker M; Thompson TC
    Cancer Gene Ther; 1999; 6(1):54-63. PubMed ID: 10078964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
    Hull GW; Mccurdy MA; Nasu Y; Bangma CH; Yang G; Shimura S; Lee HM; Wang J; Albani J; Ebara S; Sato T; Timme TL; Thompson TC
    Clin Cancer Res; 2000 Oct; 6(10):4101-9. PubMed ID: 11051263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
    Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
    Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter.
    Pramudji C; Shimura S; Ebara S; Yang G; Wang J; Ren C; Yuan Y; Tahir SA; Timme TL; Thompson TC
    Clin Cancer Res; 2001 Dec; 7(12):4272-9. PubMed ID: 11751529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
    Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
    Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer.
    Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH
    Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
    Sutton MA; Freund CT; Berkman SA; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Lerner SP
    Mol Ther; 2000 Sep; 2(3):211-7. PubMed ID: 10985951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral interleukin-3 gene-radiation therapy for prostate cancer in mouse model.
    Oh YT; Chen DW; Dougherty GJ; McBride WH
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):579-83. PubMed ID: 15145179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
    Shalev M; Kadmon D; Teh BS; Butler EB; Aguilar-Cordova E; Thompson TC; Herman JR; Adler HL; Scardino PT; Miles BJ
    J Urol; 2000 Jun; 163(6):1747-50. PubMed ID: 10799174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S; Toppinen MR; Visakorpi T; Jänne J; Wahlfors J
    Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
    Satoh T; Teh BS; Timme TL; Mai WY; Gdor Y; Kusaka N; Fujita T; Pramudji CK; Vlachaki MT; Ayala G; Wheeler T; Amato R; Miles BJ; Kadmon D; Butler EB; Thompson TC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):562-71. PubMed ID: 15145177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.